Category: Biotech

Diabetes Rearch Custom Lucite

Custom Lucite recognizing advances in the automated production of insulin secreting islet cells. (24AKL100)

2 Images

Pill-Inspired IPO Financial Tombstone

Crystal financial tombstone celebrating the initial public offering of Emcure Pharmacuticals on the Bombay Stock Exchange and National Stock Exchange. The Pune, India-based drugmaker focuses on women’s healthcare. (24AKL301)

1 Image

Crystal Tombstone for Biotech Deals

Crystal tombstone commemorting a private placement and a follow-on offering by Calidi Biotherapeutics. The San Diego-based company specializes in the development of cell-based therapies. (24AKL339)

2 Images
Top view of crystal deal tombstone marking two offerings by clinical-stage biotech company Calidi.

Pill Bottle-Inspired Deal Toy

Custom Lucite deal toy marking the acquisition of two royalty interest in sales of breast cancer drug Orserdu. (24AKL125)

2 Images
Top view of pill bottle-inspired Lucite deal tombstone.

Ogsiveo FDA Approval Commemorative

Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)

1 Image

Bayer-Pairwise Joint Venture Tombstone

Code name-themed crystal financial tombstone commemorating a  partnership between Bayer and Pairwise. The joint venture will center on gene-editing capabilities for five crops: corn, soybean, wheat, cotton, and canola. (23AJH084)

1 Image

Eyeball-Themed Crystal Deal Toy

Crystal deal toy marking a debt facility provided for Ocular Therapeutix. The biopharpharmaceutical commpany specializes in the treatment of diseases of the eye, using bioresorbable hydrogel-based technology. (23AJH088)

1 Image

Logo-Themed MedTech Offering Tombstone

Crystal financial tombstone commemorating a follow-on offering of stock by Intelligent Bio Solutions. The New York-based life sciences company develops non-invasive monitoring and diagnostic tests. (23AKL447)

1 Image

Eye-Themed Financial Tombstone

Crystal financial tombstone commemorating a public offering of common stock by Kiora Pharmaceuticals. The California-based biotech company concentrates on developing and commercializing treatments for rare retinal diseases. (23AJH059)

1 Image